Company Profile

Global Quality, Localized in Saudi
We are translating our global expertise into local impact through our upcoming Saudi complex, set to deliver an annual production capacity of 990 million healthcare solutions. By combining state-of-the-art R&amp;D, including mRNA and AI capabilities, with localized production, EVA Pharma ensures sustainable access to critical medicines. Meet us at Booth H1.U50 | Malham, Riyadh.

CPHI Middle East 2026

Event

thumbnail_EVAxCPHIQ12026_website-trial1600x1200 (1).png

EVAxCPHIQ12026_website-trial1600x1200 (1).png

By combining state-of-the-art R&D, including mRNA and AI capabilities, with localized production, EVA Pharma ensures sustainable access to critical medicines.

CPHI Middle East

Company Profile - Global

Company Profile - Saudi Arabia

Product Portfolio

Limitless Naturals Portfolio

Contract Manufacturing

Clinical Research

Animal Health Portfolio

EU- Product Portfolio

EVA Pharma is participating in WHX Dubai (formerly Arab Health), one of the region’s leading healthcare exhibitions, to share what EVA Pharma has achieved and to discuss what lies ahead for the future of the pharmaceutical field. Let’s shape the future of healthcare together by meeting our team: February 9-12 Stand 31.A56

thumbnail_EVAxWHX-Dubai_Ann_Q10126EVA-Website.png

EVAxWHX-Dubai_Ann_Q10126EVA-Website.png

EVA Pharma is participating in WHX Dubai (formerly Arab Health), one of the region’s leading healthcare exhibitions

WHX Dubai

EVA Pharma is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products. &nbsp;
With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies. &nbsp;
 Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand. &nbsp;
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 60 countries worldwide. &nbsp;

thumbnail_EVAxMIS_Ann-01-web-eng (1).png

EVAxMIS_Ann-01-web-eng (1).png

KSA Saudi Made localization Saudization Empowering health research and development

Saudi Made 2025

EVA Pharma &nbsp;is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products. &nbsp;
With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies. &nbsp;
 Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand. &nbsp;
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 60 countries worldwide. &nbsp;

thumbnail_hero-section-ss.jpg

hero-section-ss.jpg

CPHI Worldwide 2025 Frankfurt EVA Pharma is a global healthcare company operating across 70+ countries, dedicated

CPHI Worldwide 2025

EVA Pharma’s roots stretch back over a hundred years.

thumbnail_Pharmacy.jpeg

Pharmacy.jpeg

Our History

Our experienced leadership team keeps us on track.

thumbnail_Find_Out_More_Leaders.png

Find_Out_More_Leaders.png

Meet our Leaders

EVA Pharma’s success is based on its dynamic team, Our people are our power.

thumbnail_shutterstock_1578659503@2x.png

shutterstock_1578659503@2x.png

Life at EVA Pharma

thumbnail__EHCَQ2-2025_website 2.png

_EHCَQ2-2025_website 2.png

EVA Pharma at 13th Emirates Haematology Conference 2025

13th Emirates Haematology Conference 2025

thumbnail_CPHI_EVAweb 1.png

CPHI_EVAweb 1.png

EVA Pharma at CPHI Middle East Riyadh, Saudi Arabia. Bridging the globe to fulfil patients' needs with innovation, collaboration, and cutting-edge solutions.

CPHI Middle East 2024

Are you a Journalist or Media Representative and need information about us? Please feel free to get in touch with our PR Team

Happening at EVA

Event

CPHI Middle East

11

Event

09

Event

15

Event

28

Event

Media Contact

Find out more about EVA Pharma

EVA Pharma’s roots stretch back over a hundred years.

Our experienced leadership team keeps us on track.

EVA Pharma’s success is based on its dynamic team, Our people are our power.

© 2026 Eva Pharma All Rights Reserved